Takeda Drops Some Infringement Claims In Dexilant Suit
Takeda Pharmaceutical Co. Ltd. has determined that a generic rival's pursuit of a competing version of the Dexilant acid reflux treatment does not infringe a handful of its patents, according to...To view the full article, register now.
Already a subscriber? Click here to view full article